Literature DB >> 16585445

Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.

Deborah Hasin1, Sharon Samet, Edward Nunes, Jakob Meydan, Karen Matseoane, Rachel Waxman.   

Abstract

OBJECTIVE: The authors used the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV (PRISM-IV) to test the reliability of DSM-IV-defined disorders, including primary and substance-induced disorders, in substance-abusing subjects.
METHOD: Substance-abusing patients (N=285) from substance abuse/dual-diagnosis treatment settings and mental health treatment settings participated in test and blind retest interviews with the PRISM-IV, which includes specific guidelines for assessment of substance abusers.
RESULTS: Kappas for primary and substance-induced major depressive disorder ranged from 0.66 to 0.75. Reliability for psychotic disorders, eating disorders, antisocial personality disorder, and borderline personality disorder was in the same range. Reliability for most anxiety disorders was lower. Reliability was good to excellent (kappas >/=0.65) for most substance dependence disorders. Continuous measures (severity, age at onset) had intraclass correlation coefficients >0.70 with few exceptions. Reliability was better for primary than for substance-induced disorders, although not greatly so.
CONCLUSION: Most DSM-IV psychiatric disorders can be assessed in substance-abusing subjects with acceptable to excellent reliability by using specifically designed procedures. Good reliability improves the likelihood of significant study results.

Entities:  

Mesh:

Year:  2006        PMID: 16585445     DOI: 10.1176/ajp.2006.163.4.689

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  72 in total

1.  Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Analucía A Alegría; Deborah S Hasin; Edward V Nunes; Shang-Min Liu; Carrie Davies; Bridget F Grant; Carlos Blanco
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

2.  Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type.

Authors:  Kenneth R Conner; Rebecca J Houston; Marc T Swogger; Yeates Conwell; Sungeun You; Hua He; Stephanie A Gamble; Arthur Watts; Paul R Duberstein
Journal:  Drug Alcohol Depend       Date:  2011-08-10       Impact factor: 4.492

3.  Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence.

Authors:  Sharon Samet; Miriam C Fenton; Edward Nunes; Eliana Greenstein; Efrat Aharonovich; Deborah Hasin
Journal:  Addiction       Date:  2012-10-05       Impact factor: 6.526

4.  Postmortem diagnosis and toxicological validation of illicit substance use.

Authors:  Elin Lehrmann; Zoan R Afanador; Amy Deep-Soboslay; Gloria Gallegos; William D Darwin; Ross H Lowe; Allan J Barnes; Marilyn A Huestis; Jean L Cadet; Mary M Herman; Thomas M Hyde; Joel E Kleinman; William J Freed
Journal:  Addict Biol       Date:  2008-01-14       Impact factor: 4.280

5.  Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population.

Authors:  Deborah S Hasin; Dvora Shmulewitz; Malka Stohl; Eliana Greenstein; Christina Aivadyan; Kara Morita; Tulshi Saha; Efrat Aharonovich; Jeesun Jung; Haitao Zhang; Edward V Nunes; Bridget F Grant
Journal:  Drug Alcohol Depend       Date:  2015-04-06       Impact factor: 4.492

6.  Predictors of psychosis remission in psychotic disorders that co-occur with substance use.

Authors:  Carol L M Caton; Deborah S Hasin; Patrick E Shrout; Robert E Drake; Boanerges Dominguez; Sharon Samet; Bella Schanzer
Journal:  Schizophr Bull       Date:  2006-07-27       Impact factor: 9.306

Review 7.  A review of treatment options for co-occurring methamphetamine use disorders and depression.

Authors:  Tracy L Hellem; Kelly J Lundberg; Perry F Renshaw
Journal:  J Addict Nurs       Date:  2015 Jan-Mar       Impact factor: 1.476

8.  Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.

Authors:  Diane Warden; Katherine Sanchez; Tracy Greer; Thomas Carmody; Robrina Walker; Adriane Dela Cruz; Marisa Toups; Chad Rethorst; Madhukar H Trivedi
Journal:  Psychiatry Res       Date:  2016-09-15       Impact factor: 3.222

9.  The developmental course of illicit substance use from age 12 to 22: links with depressive, anxiety, and behavior disorders at age 18.

Authors:  Jennifer E Lansford; Stephen Erath; Tianyi Yu; Gregory S Pettit; Kenneth A Dodge; John E Bates
Journal:  J Child Psychol Psychiatry       Date:  2008-06-28       Impact factor: 8.982

Review 10.  Assessing addiction: concepts and instruments.

Authors:  Sharon Samet; Rachel Waxman; Mark Hatzenbuehler; Deborah S Hasin
Journal:  Addict Sci Clin Pract       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.